The apraxia of speech rating scale: A tool for diagnosis and description of apraxia of speech
•The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable. The purpose of this report is to...
Saved in:
Published in | Journal of communication disorders Vol. 51; no. NA; pp. 43 - 50 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable.
The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.
Learning Outcomes: The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech1.The reader will be able to explain characteristics of apraxia of speech.2.The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics.3.The reader will be able to explain the reliability and validity of the ASRS. |
---|---|
AbstractList | The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.
The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS. •The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall intra-judge and inter-judge reliability is acceptable.•Sensitivity and specificity of the ASRS are acceptable. The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research. Learning Outcomes: The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech1.The reader will be able to explain characteristics of apraxia of speech.2.The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics.3.The reader will be able to explain the reliability and validity of the ASRS. The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.UNLABELLEDThe purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or absence, relative frequency, and severity of characteristics frequently associated with apraxia of speech (AOS). In this paper we report intra-judge and inter-judge reliability, as well as indices of validity, for the ASRS which was completed for 133 adult participants with a neurodegenerative speech or language disorder, 56 of whom had AOS. The overall inter-judge ICC among three clinicians was 0.94 for the total ASRS score and 0.91 for the number of AOS characteristics identified as present. Intra-judge ICC measures were high, ranging from 0.91 to 0.98. Validity was demonstrated on the basis of strong correlations with independent clinical diagnosis, as well as strong correlations of ASRS scores with independent clinical judgments of AOS severity. Results suggest that the ASRS is a potentially useful tool for documenting the presence and severity of characteristics of AOS. At this point in its development it has good potential for broader clinical use and for better subject description in AOS research.The Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS.LEARNING OUTCOMESThe Apraxia of Speech Rating Scale: A new tool for diagnosis and description of apraxia of speech 1. The reader will be able to explain characteristics of apraxia of speech. 2. The reader will be able to demonstrate use of a rating scale to document the presence and severity of speech characteristics. 3. The reader will be able to explain the reliability and validity of the ASRS. Highlights • The ASRS quantifies the frequency/severity of the characteristics associated with AOS. • ASRS correlates with clinical diagnosis and severity of AOS. • Overall intra-judge and inter-judge reliability is acceptable. • Sensitivity and specificity of the ASRS are acceptable. |
Author | Strand, Edythe A. Clark, Heather M. Duffy, Joseph R. Josephs, Keith |
Author_xml | – sequence: 1 givenname: Edythe A. surname: Strand fullname: Strand, Edythe A. email: strand.edythe@mayo.edu – sequence: 2 givenname: Joseph R. orcidid: 0000-0001-8206-3432 surname: Duffy fullname: Duffy, Joseph R. email: jduffy@mayo.edu – sequence: 3 givenname: Heather M. surname: Clark fullname: Clark, Heather M. email: Clark.Heather1@mayo.edu – sequence: 4 givenname: Keith surname: Josephs fullname: Josephs, Keith email: Josephs.Keith@mayo.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25092638$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1uEzEUhS1URNPCI4C8ZJPUf-MZgyiqKgpIlVhQlsjy2HcSh4k9tScVfXs8SqigCLUrL-45n47vuUfoIMQACL2kZEEJlSfrxdrGjfN5wQgVCyIXhDRP0Iw2NZ_XSokDNCOE0blSTByio5zXpPgkpc_QIauIYpI3M_T9agXYDMn89AbHDucBwK5wMqMPS5yt6eENPsNjjD3uYsLOm2WI2WdsgsMOsk1-GH0Mk_kfznP0tDN9hhf79xh9u_hwdf5pfvnl4-fzs8u5rUU1zgUVvK0ld9RUHWlVVfLXpuIdd5J3llHiRG1aIk3V1CArZxplauoENE3dtA0_Rqc77rBtN-AshDGZXg_Jb0y61dF4_fck-JVexhstWCU4owXweg9I8XoLedQbny30vQkQt1lTqbgkkrP6EVKmVNlzw4r01Z-x7vL8Xn8RVDuBTTHnBN2dhBI91azXel-znmrWROpSc_G9veezfjRTDeV3vn_Q_X7nhlLJjYeks_UQLDifwI7aRf8g4fQewfY--HItP-AW8jpuUyh9a6oz00R_nQ5xukMqCCGVmgDv_g94RIBfmS3waA |
CitedBy_id | crossref_primary_10_1016_j_bandl_2016_09_009 crossref_primary_10_1002_14651858_CD015067_pub2 crossref_primary_10_3390_brainsci12121705 crossref_primary_10_1044_2022_AJSLP_21_00236 crossref_primary_10_1016_j_cortex_2022_02_012 crossref_primary_10_1044_2022_AJSLP_21_00355 crossref_primary_10_1080_02687038_2020_1787732 crossref_primary_10_1044_2023_AJSLP_22_00302 crossref_primary_10_1044_2023_AJSLP_22_00300 crossref_primary_10_1044_2023_AJSLP_22_00301 crossref_primary_10_1016_j_neuropsychologia_2015_12_010 crossref_primary_10_1038_s41467_021_23687_8 crossref_primary_10_1016_j_cortex_2022_10_010 crossref_primary_10_1093_brain_awad327 crossref_primary_10_1044_2015_AJSLP_14_0174 crossref_primary_10_1016_j_trci_2019_09_005 crossref_primary_10_1016_j_nicl_2018_02_036 crossref_primary_10_1080_02687038_2020_1836319 crossref_primary_10_1044_2018_AJSLP_17_0186 crossref_primary_10_3390_brainsci14060540 crossref_primary_10_1044_2022_JSLHR_22_00438 crossref_primary_10_1044_2020_JSLHR_20_00061 crossref_primary_10_1080_02687038_2017_1385050 crossref_primary_10_1080_02687038_2022_2038367 crossref_primary_10_2496_hbfr_44_156 crossref_primary_10_1080_02687038_2018_1510111 crossref_primary_10_1001_jamaneurol_2018_2287 crossref_primary_10_3390_brainsci12030378 crossref_primary_10_1080_02643294_2023_2186782 crossref_primary_10_1016_j_nrl_2022_09_003 crossref_primary_10_1016_j_brs_2019_07_007 crossref_primary_10_1016_j_nicl_2019_102152 crossref_primary_10_1590_2317_1782_20232022251en crossref_primary_10_1161_STROKEAHA_115_009211 crossref_primary_10_1515_CJAL_2024_0402 crossref_primary_10_1044_2021_AJSLP_20_00141 crossref_primary_10_1371_journal_pone_0192773 crossref_primary_10_1044_2024_JSLHR_23_00007 crossref_primary_10_1044_2017_AJSLP_16_0103 crossref_primary_10_1111_1460_6984_12494 crossref_primary_10_1016_j_clinph_2023_02_176 crossref_primary_10_1093_brain_awac454 crossref_primary_10_1016_j_bandl_2021_105025 crossref_primary_10_1080_17518423_2021_1916113 crossref_primary_10_1002_brb3_3346 crossref_primary_10_1093_cercor_bhx100 crossref_primary_10_1590_2317_1782_20232022012en crossref_primary_10_1007_s10072_023_07149_1 crossref_primary_10_1016_j_cortex_2021_03_017 crossref_primary_10_1080_13554794_2016_1172645 crossref_primary_10_3389_fneur_2021_634065 crossref_primary_10_1016_j_conctc_2024_101406 crossref_primary_10_1093_brain_awx363 crossref_primary_10_1044_2016_JSLHR_S_16_0140 crossref_primary_10_1177_15459683211017507 crossref_primary_10_1080_02699206_2024_2345353 crossref_primary_10_1016_j_bandl_2017_01_012 crossref_primary_10_1044_2020_JSLHR_20_00253 crossref_primary_10_1044_2020_AJSLP_19_00135 crossref_primary_10_1212_CPJ_0000000000000919 crossref_primary_10_1016_j_arrct_2024_100339 crossref_primary_10_6000_2292_2598_2023_11_03_1 crossref_primary_10_1016_j_cortex_2015_05_013 crossref_primary_10_1080_02643294_2020_1847059 crossref_primary_10_1002_14651858_CD015067 crossref_primary_10_1017_S0714980817000502 crossref_primary_10_1016_j_cortex_2021_01_012 crossref_primary_10_1044_2023_JSLHR_22_00439 crossref_primary_10_1080_02687038_2017_1378799 crossref_primary_10_1590_2317_1782_20232022251pt crossref_primary_10_2490_jjrmc_61_942 crossref_primary_10_1080_02687038_2021_1975636 crossref_primary_10_1080_02687038_2018_1508637 crossref_primary_10_1044_2019_JSLHR_L_RSNP_19_0021 crossref_primary_10_1044_2024_AJSLP_23_00424 crossref_primary_10_1044_2024_JSLHR_24_00304 crossref_primary_10_1016_j_bandl_2023_105314 crossref_primary_10_1044_2023_PERSP_23_00043 crossref_primary_10_1002_hbm_26704 crossref_primary_10_1097_TLD_0000000000000204 crossref_primary_10_1044_2022_AJSLP_22_00148 crossref_primary_10_1097_WNN_0000000000000371 crossref_primary_10_3390_brainsci15030271 crossref_primary_10_1044_2022_JSLHR_21_00519 crossref_primary_10_1136_jnnp_2021_328422 crossref_primary_10_1044_2022_AJSLP_22_00140 crossref_primary_10_1007_s00221_021_06224_3 crossref_primary_10_1212_CPJ_0000000000000699 crossref_primary_10_3389_fneur_2022_1013652 crossref_primary_10_1080_02687038_2017_1381876 crossref_primary_10_1007_s00415_024_12344_x crossref_primary_10_3233_ADR_220089 crossref_primary_10_1016_j_nicl_2022_102999 crossref_primary_10_1016_j_jcomdis_2020_106076 crossref_primary_10_1044_2019_AJSLP_18_0169 crossref_primary_10_1044_2021_JSLHR_21_00396 crossref_primary_10_1007_s00415_015_7821_5 crossref_primary_10_1044_2023_AJSLP_22_00296 crossref_primary_10_1212_WNL_0000000000200382 crossref_primary_10_1044_2023_JSLHR_23_00577 crossref_primary_10_1080_02687038_2020_1727709 crossref_primary_10_1111_1460_6984_12559 crossref_primary_10_1073_pnas_1614038114 crossref_primary_10_1590_2317_1782_20232022012pt crossref_primary_10_1044_2024_AJSLP_23_00208 crossref_primary_10_1080_02643294_2021_2009790 crossref_primary_10_1080_02687038_2020_1765307 crossref_primary_10_1080_02687038_2019_1602813 crossref_primary_10_1017_S1355617721000692 crossref_primary_10_1044_2022_LSHSS_21_00164 crossref_primary_10_1080_13554794_2019_1646291 crossref_primary_10_3233_ADR220089 crossref_primary_10_1044_2020_JSLHR_20_00445 crossref_primary_10_1044_2018_JSLHR_L_18_0344 crossref_primary_10_1093_brain_awae016 crossref_primary_10_1044_2018_AJSLP_17_0227 crossref_primary_10_1212_WNL_0000000000007367 crossref_primary_10_1044_2020_JSLHR_20_00340 crossref_primary_10_1044_2018_AJSLP_18_0192 crossref_primary_10_1080_17549507_2022_2061593 crossref_primary_10_1016_j_neuroimage_2022_118938 crossref_primary_10_1212_WNL_0000000000209693 crossref_primary_10_1016_j_conctc_2021_100876 crossref_primary_10_1044_2020_AJSLP_20_00126 crossref_primary_10_1044_2024_JSLHR_23_00439 crossref_primary_10_1080_02687038_2018_1545992 crossref_primary_10_1080_2050571X_2017_1388488 crossref_primary_10_21849_cacd_2018_00304 crossref_primary_10_1007_s11910_023_01275_1 crossref_primary_10_1044_2024_AJSLP_23_00345 crossref_primary_10_1093_braincomms_fcae233 crossref_primary_10_1044_2019_AJSLP_19_00005 crossref_primary_10_1044_2019_AJSLP_19_00126 crossref_primary_10_1044_2020_AJSLP_19_00110 crossref_primary_10_1044_2020_AJSLP_19_00116 crossref_primary_10_1080_02687038_2024_2314323 crossref_primary_10_1007_s10072_019_04097_7 crossref_primary_10_1093_brain_awz157 crossref_primary_10_1186_s13063_021_05238_0 crossref_primary_10_1016_j_cortex_2017_12_021 crossref_primary_10_1080_17549507_2023_2263181 crossref_primary_10_1159_000524474 crossref_primary_10_14746_pspsj_2022_29_2_17 crossref_primary_10_1044_2022_AJSLP_22_00170 crossref_primary_10_1080_13554794_2021_1933541 crossref_primary_10_1044_2017_JSLHR_S_16_0443 crossref_primary_10_1007_s00415_020_10360_1 crossref_primary_10_1016_j_neuropsychologia_2019_02_018 crossref_primary_10_1016_j_nicl_2021_102934 crossref_primary_10_3389_fnins_2021_715928 crossref_primary_10_1016_j_clinph_2019_08_011 crossref_primary_10_1016_j_cortex_2020_08_013 crossref_primary_10_1016_j_nicl_2023_103394 crossref_primary_10_1080_02643294_2017_1394834 crossref_primary_10_1080_02687038_2016_1191054 crossref_primary_10_1044_2021_AJSLP_20_00402 crossref_primary_10_1016_j_cortex_2019_11_002 crossref_primary_10_1080_2050571X_2017_1379721 crossref_primary_10_1044_2022_JSLHR_22_00347 crossref_primary_10_1080_02699206_2020_1865460 crossref_primary_10_1080_02687038_2024_2441203 crossref_primary_10_61989_6kkkds06 crossref_primary_10_1044_2024_AJSLP_24_00104 crossref_primary_10_3233_ADR_230168 crossref_primary_10_1080_02699206_2022_2099302 crossref_primary_10_1044_2018_AJSLP_MSC18_18_0099 crossref_primary_10_1044_2024_PERSP_24_00002 crossref_primary_10_1016_j_parkreldis_2025_107272 crossref_primary_10_3233_JAD_201132 crossref_primary_10_1007_s10072_024_07758_4 crossref_primary_10_1002_mds_28901 crossref_primary_10_1016_j_cortex_2019_02_029 crossref_primary_10_1016_j_cortex_2023_08_019 crossref_primary_10_1016_j_cortex_2019_05_007 crossref_primary_10_1016_j_neurobiolaging_2022_08_013 crossref_primary_10_1080_09602011_2024_2362243 crossref_primary_10_1016_j_nrleng_2022_09_006 crossref_primary_10_1007_s00702_022_02550_0 crossref_primary_10_1161_STROKEAHA_115_010402 crossref_primary_10_1044_2023_AJSLP_22_00319 crossref_primary_10_1093_brain_awx293 crossref_primary_10_1044_2020_AJSLP_20_00135 crossref_primary_10_1016_j_nicl_2016_01_014 crossref_primary_10_1044_2020_AJSLP_20_00012 crossref_primary_10_1515_CJAL_2021_0035 crossref_primary_10_1044_2023_JSLHR_23_00242 crossref_primary_10_1044_2018_JSLHR_L_18_0048 crossref_primary_10_1016_j_jcomdis_2021_106090 crossref_primary_10_3233_JAD_230912 crossref_primary_10_3389_fneur_2021_694872 crossref_primary_10_1111_ene_15764 crossref_primary_10_1044_2019_AJSLP_CAC48_18_0227 crossref_primary_10_1044_2019_JSLHR_L_19_0213 crossref_primary_10_1111_nan_12535 crossref_primary_10_1016_j_bandl_2023_105254 crossref_primary_10_1044_2024_JSLHR_24_00049 crossref_primary_10_1044_2021_AJSLP_21_00058 crossref_primary_10_1044_2019_AJSLP_CAC48_18_0224 crossref_primary_10_1016_j_jns_2016_08_048 crossref_primary_10_1044_2019_AJSLP_CAC48_18_0225 |
Cites_doi | 10.1080/02687030600597358 10.1093/brain/awl078 10.1044/1058-0360.0503.07 10.1093/brain/aws032 10.1097/WCO.0b013e3283168ddd 10.1044/1092-4388(2012/11-0318) |
ContentType | Journal Article |
Copyright | 2014 Elsevier Inc. Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. 2014 Elsevier Inc. All rights reserved. 2014 |
Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. – notice: 2014 Elsevier Inc. All rights reserved. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.jcomdis.2014.06.008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Psychology |
EISSN | 1873-7994 |
EndPage | 50 |
ExternalDocumentID | PMC4254321 25092638 10_1016_j_jcomdis_2014_06_008 S0021992414000598 1_s2_0_S0021992414000598 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDCD NIH HHS grantid: R01 DC 10367 – fundername: NIDCD NIH HHS grantid: R01 DC000496 – fundername: NIDCD NIH HHS grantid: R01 DC010367 – fundername: NIDCD NIH HHS grantid: R01 DC 00496 |
GroupedDBID | --- --K --M --Z -RU -~X .1- .FO .GJ .~1 0R~ 186 1B1 1P~ 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 85S 8P~ 9JM 9JO AADFP AAEDT AAEDW AAFJI AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXLA AAXUO AAYJJ AAYWO ABBQC ABCQJ ABDPE ABIVO ABJNI ABLJU ABMAC ABMMH ABMZM ABOYX ABWJO ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACJTP ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXBA AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP ASPBG AVARZ AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMW HMY HVGLF HZ~ IHE J1W KOM KOO M3V M3Y M41 MO0 MOBAO N9A NHB O-L O9- OAUVE OH0 OHT OKEIE OU- OZT P-8 P-9 P2P PC. PRBVW Q38 R2- ROL RPZ SDF SDG SDP SES SEW SNG SPCBC SPS SSB SSH SSN SSO SSS SSY SSZ T5K TN5 TWZ UHS WH7 WUQ XJT XOL YQT YYQ Z5R ZCG ZGI ZUP ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG YCJ AADPK AAIAV ABLVK ABYKQ AFYLN AGHSJ AISVY AJBFU AKYCK EFLBG G8K LCYCR NAHTW AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c745t-4143b763d1a5f0b957997a53f3d63fc210d47ab06a587e65da89a71d4e8878b83 |
IEDL.DBID | .~1 |
ISSN | 0021-9924 1873-7994 |
IngestDate | Thu Aug 21 18:27:15 EDT 2025 Fri Jul 11 03:20:04 EDT 2025 Tue Aug 05 09:37:46 EDT 2025 Thu Apr 03 07:02:44 EDT 2025 Tue Jul 01 03:24:04 EDT 2025 Thu Apr 24 23:00:48 EDT 2025 Fri Feb 23 02:25:22 EST 2024 Sun Feb 23 10:19:44 EST 2025 Tue Aug 26 16:32:01 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | NA |
Keywords | Differential diagnosis Apraxia of speech Subject description Assessment |
Language | English |
License | Copyright © 2014 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c745t-4143b763d1a5f0b957997a53f3d63fc210d47ab06a587e65da89a71d4e8878b83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8206-3432 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/4254321 |
PMID | 25092638 |
PQID | 1629966182 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4254321 proquest_miscellaneous_1693606327 proquest_miscellaneous_1629966182 pubmed_primary_25092638 crossref_primary_10_1016_j_jcomdis_2014_06_008 crossref_citationtrail_10_1016_j_jcomdis_2014_06_008 elsevier_sciencedirect_doi_10_1016_j_jcomdis_2014_06_008 elsevier_clinicalkeyesjournals_1_s2_0_S0021992414000598 elsevier_clinicalkey_doi_10_1016_j_jcomdis_2014_06_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-09-01 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of communication disorders |
PublicationTitleAlternate | J Commun Disord |
PublicationYear | 2014 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Wertz, LaPointe, Rosenbek (bib0060) 1984 McNeil, Doyle, Wambaugh (bib0055) 2000 Duffy (bib0010) 2013 Kertesz (bib0045) 2007 Darley (bib0005) 1968 Josephs, Duffy, Strand, Whitwell, Layton, Parisi (bib0025) 2006; 129 Josephs, Duffy, Strand, Machulda, Senjem, Master (bib0030) 2012; 135 Kent (bib0040) 1996; 5 McNeil, Robin, Schmidt (bib0050) 2009 Duffy (bib0015) 2006; 20 Haley, Jacks, de Riesthal, Abou-Khalil, Roth (bib0020) 2012; 55 Josephs, Duffy (bib0035) 2008; 21 Duffy (10.1016/j.jcomdis.2014.06.008_bib0015) 2006; 20 Josephs (10.1016/j.jcomdis.2014.06.008_bib0030) 2012; 135 Kent (10.1016/j.jcomdis.2014.06.008_bib0040) 1996; 5 Kertesz (10.1016/j.jcomdis.2014.06.008_bib0045) 2007 Josephs (10.1016/j.jcomdis.2014.06.008_bib0035) 2008; 21 Haley (10.1016/j.jcomdis.2014.06.008_bib0020) 2012; 55 McNeil (10.1016/j.jcomdis.2014.06.008_bib0055) 2000 Josephs (10.1016/j.jcomdis.2014.06.008_bib0025) 2006; 129 McNeil (10.1016/j.jcomdis.2014.06.008_bib0050) 2009 Wertz (10.1016/j.jcomdis.2014.06.008_bib0060) 1984 Darley (10.1016/j.jcomdis.2014.06.008_bib0005) 1968 Duffy (10.1016/j.jcomdis.2014.06.008_bib0010) 2013 16613895 - Brain. 2006 Jun;129(Pt 6):1385-98 18989114 - Curr Opin Neurol. 2008 Dec;21(6):688-92 22382356 - Brain. 2012 May;135(Pt 5):1522-36 23033444 - J Speech Lang Hear Res. 2012 Oct;55(5):S1502-17 |
References_xml | – year: 1968 ident: bib0005 article-title: Apraxia of speech: 107 Years of terminological confusion publication-title: Paper presented at the American speech and Hearing Association – year: 2013 ident: bib0010 article-title: Motor speech disorders: Substrates, differential diagnosis, and management – year: 2007 ident: bib0045 article-title: Western aphasia battery (revised) – volume: 5 start-page: 7 year: 1996 end-page: 23 ident: bib0040 article-title: Hearing and believing: Some limits to the auditory-perceptual assessment of speech and voice disorders publication-title: American Journal of Speech-Language Pathology – volume: 55 start-page: S1502 year: 2012 end-page: S1517 ident: bib0020 article-title: Toward a quantitative basis for assessment and diagnosis of apraxia of speech publication-title: Journal of Speech Language and Hearing Research – year: 1984 ident: bib0060 article-title: Apraxia of speech in adults: The disorder and its management – volume: 129 start-page: 1385 year: 2006 end-page: 1398 ident: bib0025 article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech publication-title: Brain – start-page: 221 year: 2000 end-page: 266 ident: bib0055 article-title: Apraxia of speech: A treatable disorder of motor planning and programming publication-title: Aphasia and language: Theory to practice – volume: 20 start-page: 511 year: 2006 end-page: 527 ident: bib0015 article-title: Apraxia of speech in degenerative neurologic disease publication-title: Aphasiology – volume: 135 start-page: 1522 year: 2012 end-page: 1536 ident: bib0030 article-title: Characterizing a neurodegenerative syndrome: Primary progressive apraxia of speech publication-title: Brain – start-page: 249 year: 2009 end-page: 268 ident: bib0050 article-title: Apraxia of speech publication-title: Clinical management of sensorimotor speech disorders – volume: 21 start-page: 688 year: 2008 end-page: 692 ident: bib0035 article-title: Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy publication-title: Current Opinion in Neurology – start-page: 221 year: 2000 ident: 10.1016/j.jcomdis.2014.06.008_bib0055 article-title: Apraxia of speech: A treatable disorder of motor planning and programming – year: 1968 ident: 10.1016/j.jcomdis.2014.06.008_bib0005 article-title: Apraxia of speech: 107 Years of terminological confusion – volume: 20 start-page: 511 year: 2006 ident: 10.1016/j.jcomdis.2014.06.008_bib0015 article-title: Apraxia of speech in degenerative neurologic disease publication-title: Aphasiology doi: 10.1080/02687030600597358 – volume: 129 start-page: 1385 year: 2006 ident: 10.1016/j.jcomdis.2014.06.008_bib0025 article-title: Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech publication-title: Brain doi: 10.1093/brain/awl078 – year: 2007 ident: 10.1016/j.jcomdis.2014.06.008_bib0045 – year: 2013 ident: 10.1016/j.jcomdis.2014.06.008_bib0010 – volume: 5 start-page: 7 year: 1996 ident: 10.1016/j.jcomdis.2014.06.008_bib0040 article-title: Hearing and believing: Some limits to the auditory-perceptual assessment of speech and voice disorders publication-title: American Journal of Speech-Language Pathology doi: 10.1044/1058-0360.0503.07 – year: 1984 ident: 10.1016/j.jcomdis.2014.06.008_bib0060 – volume: 135 start-page: 1522 issue: May (Pt 5) year: 2012 ident: 10.1016/j.jcomdis.2014.06.008_bib0030 article-title: Characterizing a neurodegenerative syndrome: Primary progressive apraxia of speech publication-title: Brain doi: 10.1093/brain/aws032 – volume: 21 start-page: 688 year: 2008 ident: 10.1016/j.jcomdis.2014.06.008_bib0035 article-title: Apraxia of speech and nonfluent aphasia: A new clinical marker for corticobasal degeneration and progressive supranuclear palsy publication-title: Current Opinion in Neurology doi: 10.1097/WCO.0b013e3283168ddd – volume: 55 start-page: S1502 year: 2012 ident: 10.1016/j.jcomdis.2014.06.008_bib0020 article-title: Toward a quantitative basis for assessment and diagnosis of apraxia of speech publication-title: Journal of Speech Language and Hearing Research doi: 10.1044/1092-4388(2012/11-0318) – start-page: 249 year: 2009 ident: 10.1016/j.jcomdis.2014.06.008_bib0050 article-title: Apraxia of speech – reference: 18989114 - Curr Opin Neurol. 2008 Dec;21(6):688-92 – reference: 16613895 - Brain. 2006 Jun;129(Pt 6):1385-98 – reference: 22382356 - Brain. 2012 May;135(Pt 5):1522-36 – reference: 23033444 - J Speech Lang Hear Res. 2012 Oct;55(5):S1502-17 |
SSID | ssj0016611 |
Score | 2.4720256 |
Snippet | •The ASRS quantifies the frequency/severity of the characteristics associated with AOS.•ASRS correlates with clinical diagnosis and severity of AOS.•Overall... Highlights • The ASRS quantifies the frequency/severity of the characteristics associated with AOS. • ASRS correlates with clinical diagnosis and severity of... The purpose of this report is to describe an initial version of the Apraxia of Speech Rating Scale (ASRS), a scale designed to quantify the presence or... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 43 |
SubjectTerms | Adult Aged Aged, 80 and over Aphasia - diagnosis Apraxia of speech Apraxias - diagnosis Assessment Diagnosis, Differential Differential diagnosis Humans Middle Aged Observer Variation Psychiatry Reproducibility of Results Speech Production Measurement - methods Subject description |
Title | The apraxia of speech rating scale: A tool for diagnosis and description of apraxia of speech |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0021992414000598 https://www.clinicalkey.es/playcontent/1-s2.0-S0021992414000598 https://dx.doi.org/10.1016/j.jcomdis.2014.06.008 https://www.ncbi.nlm.nih.gov/pubmed/25092638 https://www.proquest.com/docview/1629966182 https://www.proquest.com/docview/1693606327 https://pubmed.ncbi.nlm.nih.gov/PMC4254321 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRUK9ICivtFAtEtc87N312tyiiCo8WiFEpV7Qah8T6qiyozqV6IXfzoxfEFJRxClKsmPHO7PfzGS_mWXstYh8im7NDVWgv24kLiknFQy9DkkasgBaUjXyyWkyP5Pvz9X5Dpt1tTBEq2yxv8H0Gq3bT8btbI5XeU41vjFxJyWmCFRCSQW_Umqy8tGPnuYRof9pTs0jKgKO_lXFM16OlnjxkFPX7kjWbTzplMnb_dN2_PknjfI3v3T8kD1oA0o-bX7zI7YDxT67f9Jume-zvR7ibh6zr2gV3K6u7Pfc8nLBqxWAv-BkBcU3XqG-4A2f8nVZXnKMZnloiHh5xW0ReIAeY0h46zpP2Nnx2y-z-bA9YAFVIdV6iFMnHAJMiKxaTBzt2GXaKrEQIRELj9lgkNq6SWJVqiFRwaaZ1VGQgNCUulQ8ZbtFWcBzxqVX3qEMJBIkTEIWCQDhnYdMuODSAZPdtBrfdh-nQzAuTUczW5pWG4a0YWq6HYqNerFV037jLoGk05npaksRDQ06iLsE9W2CULVrujKRqWIzMVt2N2BpL7lhuv9y01edWRlc1rRXYwsor_FmSUyZKGZ_fxuTCcw_RawH7Fljiv0kYWSbxYit-FgbRtoPoLbim98U-UXdXlxSf4Q4Ovj_xzpke_SuoeK9YLvrq2t4ibHb2h3Vi_OI3ZvOPn_8RK_vPsxPfwJINEbU |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXBOW1PI3EdR-J7cThVlVUC3R7aqVekGXHs21WVbJqthJc-ts7kziBZSuKuG48ycYz881MPA_GPooo12jW3FB5-nQjUaWcVDDMU59on3lIJVUjz46S6Yn8eqpOt9h-VwtDaZUB-1tMb9A6_DIOuzleFgXV-MaUOykxRKASSn2P3ZeovjTGYHTd53lEaIDasXmUi4DLf5XxjBejBd7dF9S2O5JNH08aM3m7gdp0QP_Mo_zNMB08Zo-CR8n32j_9hG1BucsezMKZ-S7b6THu51P2HcWC2-Wl_VFYXs15vQTIzzmJQXnGa2QYfOJ7fFVVFxzdWe7bTLyi5rb03EMPMkS8cZ9n7OTg8_H-dBgmLCAvpFoNce-EQ4TxkVXziaMjuyy1SsyFT8Q8x3DQy9S6SWKVTiFR3urMppGXgNiknRbP2XZZlfCScZmr3CENJBIkTHwWCQCRuxwy4bzTAya7bTV5aD9OUzAuTJdntjCBG4a4YZp8OyQb9WTLtv_GXQRJxzPTFZciHBq0EHcRprcRQh2UujaRqWMzMRuCN2C6p1yT3X956IdOrAzqNR3W2BKqK3xYElMoiuHf39ZkAgNQEacD9qIVxX6T0LXNYgRXfK01Ie0XUF_x9Stlcd70F5fUICGOXv3_a71nD6fHs0Nz-OXo22u2Q1favLw3bHt1eQVv0ZFbuXeNot4AH1RGzQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+apraxia+of+speech+rating+scale%3A+A+tool+for+diagnosis+and+description+of+apraxia+of+speech&rft.jtitle=Journal+of+communication+disorders&rft.au=Strand%2C+E+A&rft.au=Duffy%2C+J+R&rft.au=Clark%2C+H+M&rft.au=Josephs%2C+K&rft.date=2014-09-01&rft.issn=0021-9924&rft.volume=51&rft.issue=NA&rft_id=info:doi/10.1016%2Fj.jcomdis.2014.06.008&rft.externalDBID=NO_FULL_TEXT |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219924%2FS0021992414X00067%2Fcov150h.gif |